Allison Tyler
California Institute of Technology(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Cancer, Hypoxia, and Metabolism, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Phase 1 dose‐escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma(2010)153 cited
- → A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors(2009)85 cited
- → HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer(2018)52 cited
- → The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma(2018)49 cited
- → Toxicity of Sunitinib Plus Bevacizumab in Renal Cell Carcinoma(2010)45 cited
- → A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC)(2018)42 cited
- → An Unexpected Surge in Plasma BKPyV Viral Load Heralds the Development of BKPyV-Associated Metastatic Bladder Cancer in a Lung Transplant Recipient With BKPyV Nephropathy(2016)19 cited
- → Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial(2013)19 cited
- → Urothelial Cancers: Ureter, Renal Pelvis, and Bladder(2012)18 cited
- → Assessment of owner willingness to treat or manage diseases of dogs and cats as a guide to shelter animal adoptability(2012)17 cited